Biological Description

Specificity HIP1 Antibody (Rabbit mAb) [B10P18] detects endogenous levels of total HIP1 protein.
Background HIP1 (huntingtin‑interacting protein 1) is a membrane‑associated endocytic adaptor that links clathrin‑coated pit dynamics to receptor trafficking, cytoskeletal organization, and oncogenic signaling, and belongs to the Sla2/HIP family of clathrin–actin adaptors conserved from yeast to mammals. The protein contains an N‑terminal ANTH domain that binds phosphoinositides in the plasma membrane, a central coiled‑coil region that associates with clathrin light chains and AP‑2, and a C‑terminal talin‑like domain with actin‑binding and putative death‑effector homology, creating a modular scaffold that couples membranes, clathrin lattices, and actin filaments during coated pit initiation and maturation. HIP1 is an early‑recruited accessory factor at nascent clathrin‑coated pits that remains associated through late stages of pit maturation and scission, where it stabilizes clathrin assembly, influences coated pit lifetimes, and helps coordinate the transition from flat lattices to deeply invaginated buds that undergo dynamin‑dependent fission. These structural and temporal features place HIP1 at a nodal point in clathrin‑mediated endocytosis of receptor tyrosine kinases and other signaling receptors, and loss or inhibition of HIP1 accelerates ligand‑induced internalization and degradation of receptors such as EGFR, while HIP1 overexpression enhances receptor stability at or near the plasma membrane, prolonging signaling through pathways like PI3K–Akt and contributing to growth‑factor–dependent survival and proliferation. HIP1 also binds huntingtin, and the interaction is reduced by polyglutamine expansion, linking altered HIP1 availability and endocytic/cytoskeletal functions to Huntington‑related neurodegeneration, whereas in non‑neuronal tissues HIP1 overexpression shows transforming properties, cooperates with receptor signaling to drive anchorage‑independent growth, and participates in leukemia‑associated fusion events, identifying HIP1 as an endocytic protein with intrinsic oncogenic potential. Clinical studies in acute myeloid leukemia and solid tumors report elevated HIP1 expression in subsets of patients, with high HIP1 transcript levels correlating with adverse overall survival, specific mutational backgrounds, and altered microRNA profiles, and siRNA‑mediated HIP1 knockdown in leukemic cells reduces proliferation, supporting a functional role in tumor maintenance and suggesting value as a prognostic marker and therapeutic target in cancers that depend on sustained receptor signaling and endocytic rewiring. HIP1 functions as a phosphoinositide‑ and clathrin‑binding adaptor that stabilizes coated pits, couples them to actin, and modulates receptor endocytosis and trafficking, and its dysregulated expression or disrupted interaction with huntingtin links perturbations of vesicle dynamics both to oncogenic signaling networks and to neurodegenerative mechanisms.

Usage Information

Application WB, IP, IF Dilution
WB IP IF
1:1000 - 1:10000 1:20 - 1:40 1:100 - 1:250
Reactivity Mouse, Human
Source Rabbit Monoclonal Antibody MW 116 kDa
Storage Buffer PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Storage
(from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 5%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use primary antibody dilution buffer to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:2000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
IF
Experimental Protocol:
 
Sample Preparation
1. Adherent Cells: Place a clean, sterile coverslip in a culture dish. Once the cells grow to near confluence as a monolayer, remove the coverslip for further use.
2. Suspension Cells: Seed the cells onto a clean, sterile slide coated with poly-L-lysine.
3. Frozen Sections: Allow the slide to thaw at room temperature. Wash it with pure water or PBS for 2 times, 3 minutes each time.
4. Paraffin Sections: Deparaffinization and rehydration. Wash the slide with pure water or PBS for 3 times, 3 minutes each time. Then perform antigen retrieval.
 
Fixation
1. Fix the cell coverslips/spots or tissue sections at room temperature using a fixative such as 4% paraformaldehyde (4% PFA) for 10-15 minutes.
2. Wash the sample with PBS for 3 times, 3 minutes each time.
 
Permeabilization
1.Add a detergent such as 0.1–0.3% Triton X-100 to the sample and incubate at room temperature for 10–20 minutes.
(Note: This step is only required for intracellular antigens. For antigens expressed on the cell membrane, this step is unnecessary.)
Wash the sample with PBS for 3 times, 3 minutes each time.
 
Blocking
Add blocking solution and incubate at room temperature for at least 1 hour. (Common blocking solutions include: serum from the same source as the secondary antibody, BSA, or goat serum.)
Note: Ensure the sample remains moist during and after the blocking step to prevent drying, which can lead to high background.
 
Immunofluorescence Staining (Day 1)
1. Remove the blocking solution and add the diluted primary antibody.
2. Incubate the sample in a humidified chamber at 4°C overnight.
 
Immunofluorescence Staining (Day 2)
1. Remove the primary antibody and wash with PBST for 3 times, 5 minutes each time.
2. Add the diluted fluorescent secondary antibody and incubate in the dark at 4°C for 1–2 hours.
3. Remove the secondary antibody and wash with PBST for 3 times, 5 minutes each time.
4. Add diluted DAPI and incubate at room temperature in the dark for 5–10 minutes.
5. Wash with PBST for 3 times, 5 minutes each time.
 
Mounting
1. Mount the sample with an anti-fade mounting medium.
2. Allow the slide to dry at room temperature overnight in the dark.
3. Store the slide in a slide storage box at 4°C, protected from light.
 

References

  • https://pubmed.ncbi.nlm.nih.gov/15059611/
  • https://pubmed.ncbi.nlm.nih.gov/19626275/

Application Data

WB

Validated by Selleck

  • F5844-wb
    Lane 1: HCT116, Lane 2: Hela, Lane 3: Jurkat